D
Donald S. Baim
Researcher at Harvard University
Publications - 98
Citations - 15792
Donald S. Baim is an academic researcher from Harvard University. The author has contributed to research in topics: Angioplasty & Restenosis. The author has an hindex of 52, co-authored 98 publications receiving 15481 citations. Previous affiliations of Donald S. Baim include Dana Corporation & Eastman Kodak Company.
Papers
More filters
Journal ArticleDOI
A Randomized Comparison of Coronary-Stent Placement and Balloon Angioplasty in the Treatment of Coronary Artery Disease
David L. Fischman,Martin B. Leon,Donald S. Baim,Richard A. Schatz,Michael P. Savage,Ian M. Penn,Katherine D. Detre,Lisa Veltri,Donald R. Ricci,Masakiyo Nobuyoshi,Michael W. Cleman,Richard R. Heuser,David Almond,Paul S. Teirstein,R. David Fish,Antonio Colombo,Jeffrey C. Brinker,Jeffrey Moses,Alex Shaknovich,John N. Hirshfeld,Stephen Bailey,Stephen E. Ellis,Randal Rake,Sheldon Goldberg +23 more
TL;DR: In selected patients, placement of an intracoronary stent, as compared with balloon angioplasty, results in an improved rate of procedural success, a lower rate of angiographically detected restenosis, a similar rate of clinical events after six months, and a less frequent need for revascularization of the original coronary lesion.
Journal ArticleDOI
A Clinical Trial Comparing Three Antithrombotic-Drug Regimens after Coronary-Artery Stenting
Martin B. Leon,Donald S. Baim,Jeffrey J. Popma,Paul C. Gordon,Donald E. Cutlip,Kalon K.L. Ho,Alex Giambartolomei,Daniel J. Diver,David Lasorda,David O. Williams,Stuart J. Pocock,Richard E. Kuntz +11 more
TL;DR: This study compared the efficacy and safety of three antithrombotic-drug regimens — aspirin alone, aspirin and warfarin, and aspirin and ticlopidine — after coronary stenting to prevent stent thrombosis.
Journal ArticleDOI
A Clinical Trial Comparing Three Antithrombotic-Drug Regimens After Coronary Artery Stenting
Martin B. Leon,Donald S. Baim,Jeffrey J. Popma,Paul C. Gordon,Donald E. Cutlip,Kalon K.L. Ho,Alex Giambartolomei,Daniel J. Diver,David Lasorda,David O. Williams,Stuart J. Pocock,Richard E. Kuntz +11 more
TL;DR: Treatment with aspirin and ticlopidine after coronary stenting resulted in a lower rate of stent thrombosis, although there were more hemorrhagic complications than with aspirin alone.
Journal ArticleDOI
Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part II.
Gregg W. Stone,David E. Kandzari,Roxana Mehran,Antonio Colombo,Robert S. Schwartz,Steven R. Bailey,Issam Moussa,Paul S. Teirstein,George Dangas,Donald S. Baim,Matthew Selmon,Bradley H. Strauss,Hideo Tamai,Takahiko Suzuki,Kazuaki Mitsudo,Osamu Katoh,David A. Cox,Angela Hoye,Gary S. Mintz,Eberhard Grube,Louis Cannon,Nicolaus Reifart,Mark Reisman,Alexander Abizaid,Jeffrey W. Moses,Martin B. Leon,Patrick W. Serruys +26 more
TL;DR: The technical approach to and outcomes after percutaneous coronary intervention (PCI) of occluded coronary arteries, as well as the novel devices and drugs approved and undergoing investigation for CTO recanalization, are summarized.
Journal ArticleDOI
Incidence and treatment of 'no-reflow' after percutaneous coronary intervention.
Robert N. Piana,GY Paik,Mauro Moscucci,David J. Cohen,Gibson Cm,Aaron D. Kugelmass,Jr Jp Carrozza,Richard E. Kuntz,Donald S. Baim +8 more
TL;DR: The no-reflow phenomenon--reduction in distal flow without apparent dissection or distal embolization--occurs in 2% of coronary interventions and generally responds promptly to intracoronary verapamil administration, suggesting that distal microvascular spasm may be its etiology.